Cytokine Gene Polymorphism in BCG Lymphadenopathy
Authors
Abstract:
Background: Tumor necrosis factor-beta or lymphotoxin-alpha (LT-α), IL-4 and IL-10 are determining factors in immunity against BCG. Allelic polymorphisms in the regulatory regions of their genes affect the rate of cytokine production and therefore, the host’s ability in BCG containment. Objective: To study the prevalence of –590 (C/T) and –592 (C/A) allelic distribution of IL-4 and IL-10 promoter regions, respectively, and +282 (G/A) polymorphism in the first intron of LT-α in BCG vaccinees with lymphadenopathy comparing to those of controls. Methods: Polymorphisms in the promoter region of IL-4 and IL-10 were determined by primer induced restriction site PCR and the polymorphism in the first intron of LT-α was investigated using PCR-RFLP method. Forty patients with BCG adenitis and 42 healthy age-matched infants without reactions were included in this study. Results: No significant differences existed between allele and genotype frequencies of IL-4 or LT-α genes from patients as compared to the controls. A significant difference in genotype distribution of the IL-10 –592 C-to-T polymorphism was observed between patients and controls (p<0.05). In this respect, the AA and AC genotypes with lower ability in IL-10 production were found more frequently in the control group. Conclusion: The lower frequency of AA genotype at position –592 of IL-10 promoter region in patients may have resulted in more IL-10 production leading to weaker immune response that allows bacterial burden and occurrence of lymphadenitis.
similar resources
cytokine gene polymorphism in bcg lymphadenopathy
background: tumor necrosis factor-beta or lymphotoxin-alpha (lt- α ), il-4 and il-10 are determining factors in immunity against bcg. allelic polymorphisms in the regulatory regions of their genes affect the rate of cytokine production and therefore, the host’s ability in bcg containment. objective : to study the prevalence of –590 (c/t) and –592 (c/a) allelic distribution of il-4 and il-10 ...
full textBCG lymphadenopathy detected in a BCG-vaccinated infant.
Large-scale vaccination with BCG, the live attenuated strain of Mycobacterium bovis, is being adopted around the world, although sporadic complications have occurred after the procedure. Lymphadenopathy is not uncommon especially in babies under one year (0.73% of vaccinated infants), but the swelling subsides within 2 months in most cases, with no medical or surgical treatment. Brazil adopted ...
full textTh1 and Th2 Cytokine Gene Polymorphism in Iranian Patients with Chronic Myelogenous Leukemia
Background:It has been hypothesized that genetic factors other than histocompatibility disparity may play a role in predisposition to developing Chronic Myelogenous Leukemia (CML). In this regard, Th1 and Th2 cytokines and their gene polymorphism seems to be important. Overall expression and secretion of cytokines is dependent, at least in part, on genetic polymorphism (nucleotide variations) w...
full textCytokine gene polymorphism in recurrent acute otitis media.
BACKGROUND There is increasing evidence that a strong genetic component is involved in the predisposition to recurrent acute otitis media (rAOM). Cytokines play a key role in the pathogenesis of otitis media. Constitutional polymorphisms in cytokine genes may lead to individual variations in cytokine secretion. OBJECTIVE To elucidate the role of cytokine gene polymorphisms in rAOM. SETTING ...
full textPatterns of cytokine gene expression in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type.
Peripheral T-cell lymphoma of angioimmunoblastic lymph-adenopathy type (AILD-TCL) is histologically characterized by a mixed infiltrate of atypical T cells, B cells including B immunoblasts, and plasma cells, as well as eosinophilic granulocytes accompanied by proliferated high endothelial venules, while, clinically, fever and weight loss are often observed. These morphologic and clinical pecul...
full textMy Resources
Journal title
volume 27 issue 3
pages 125- 130
publication date 2015-11-30
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023